CFDE Data Portal | Search KRT19

	Label	Description
	KRT19 Gene (Entity type)	ENSG00000171345 - keratin 19
	LINCS phase 2 Project (Entity type)	The LINCS Consortium is an NIH Common Fund program that supports six Data and Signature Generation C...
	THRA Gene (Entity type)	ENSG00000126351 - thyroid hormone receptor alpha
	NDUFB6 Gene (Entity type)	ENSG00000165264 - NADH:ubiquinone oxidoreductase subunit B6
	PAFAH1B3 Gene (Entity type)	ENSG00000079462 - platelet activating factor acetylhydrolase 1b catalytic subunit 3
	USP9X Gene (Entity type)	ENSG00000124486 - ubiquitin specific peptidase 9 X-linked
	TMEM41B Gene (Entity type)	ENSG00000166471 - transmembrane protein 41B
	GSE216043 7 V 9 CISPLATIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	TMEM140 Gene (Entity type)	ENSG00000146859 - transmembrane protein 140
	GSE144443 0 V 6 NICOTINAMIDE MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS

KRT19

ENSG00000171345 - keratin 19

LINCS phase 2

The LINCS Consortium is an NIH Common Fund program that supports six Data and Signature Generation C...

THRA

ENSG00000126351 - thyroid hormone receptor alpha

NDUFB6

ENSG00000165264 - NADH:ubiquinone oxidoreductase subunit B6

PAFAH1B3

ENSG00000079462 - platelet activating factor acetylhydrolase 1b catalytic subunit 3

USP9X

ENSG00000124486 - ubiquitin specific peptidase 9 X-linked

TMEM41B

ENSG00000166471 - transmembrane protein 41B

GSE216043 7 V 9 CISPLATIN HUMAN DN

A Gene Set from LINCS

TMEM140

ENSG00000146859 - transmembrane protein 140

GSE144443 0 V 6 NICOTINAMIDE MOUSE UP

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.